Back To Search Results

Oral Melanoacanthoma

Editor: Melina Brizuela Updated: 3/19/2023 2:00:56 PM

Introduction

Oral melanoacanthoma is a rare, benign macular brown-black lesion, which is usually asymptomatic, and distinguished by the sudden appearance and rapid growth. It is found to be secondary to tissue trauma and is self-limiting in nature. In the literature, up to 75% of reported cases are labeled as reactive.[1]

Histologically it presents with acanthosis of the superficial epithelium and proliferation of dendritic melanocytes.[2]

The most common location of oral melanoacanthomas is the buccal mucosa, but they can also be seen in labial mucosa, palate, gingiva, alveolar mucosa, and oropharynx.[1] There are two recognized phenotypes, the multifocal and the singular, the most common of which is the latter.

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

The etiology of oral melanoacanthoma is yet to be determined, but it is mostly associated with a traumatic process that stimulates melanocyte activity.[3] This is supported by the reactive infiltrate of eosinophils found on histopathology, which corroborates the reactive nature. A review of 56 articles of 115 cases concluded that 77% of authors found an association with a reactive etiology.[1]

Chronic trauma, or chemical irritants, stimulates melanocytes, which result in either oral pigmentation or a melanoacanthoma.

Regular contact with petroleum derivatives found in toothpaste and mouthwashes may act as an irritant agent. These derivates include sodium lauryl sulfate, phenolphthalein, nitrophenol, chlorophenol, phenylenediamine sulfate, amine fluorideco, and cocamidopropyl betaine. Hydrogen peroxide mouthwashes can also irritate the oral mucosa and cause melanoacanthoma.

Silver amalgam has also been described as an etiologic factor that may cause morphologic changes and pigmentation and dental restoration with other materials.[1]

Bruxism, biting of the cheeks, poorly fitted removable prosthesis, implant surgery, and non-specific chronic trauma have been reported features anteceding the presentation of an oral melanoacanthoma.

Other etiologic factors include patients treated for chronic asthma and ferrous lactate chronic treatment for iron-deficiency anemia.

Epidemiology

Oral Melanoacanthoma may occur at any stage in adult life, but it is predominantly encountered in the younger age group with a median age of diagnosis of 35 years old. It has a female predilection with a ratio of 3 to 2. It is mostly seen in dark-skinned patients, followed by non-Hispanic Whites and Hispanics.[1][2] Solitary lesions are more frequently observed in the buccal mucosa, unlike multifocal ones that tend to occur mostly on the palate.[4]

Pathophysiology

Oral melanoacanthomas usually grow rapidly, and therefore they often mimic the radial growth phase of an intraoral melanoma. It has been suggested that chronic mechanical trauma, or chemical irritants, may stimulate melanocytic activity.[1][5]

Histopathology

A biopsy is mandatory for diagnosing oral melanoacanthoma and will demonstrate dendritic melanocytes and spinous keratinocytes.[6] The dendritic melanocytes will be clearly defined and contained in an acanthotic epithelium.[7][8] This is in contrast to oral melanoma, in which the melanocytes will cross the lamina propria. The dendritic melanocytes are usually demonstrated by the Masson-Fontana silver impregnation stain. The adjacent connective tissue exhibits inflammatory infiltrate in the great majority of cases.[2]

History and Physical

The presentation typically involves a history of new darkening or dark spots in the mouth, generally brown or black, well-circumscribed, flat, or raised.Almost half of the lesions are located on the buccal mucosa, followed by the palate and lips and, less commonly, the gums.[1][9][4] They are usually asymptomatic but rarely may be painful or itchy. History of new mouthwash or toothpaste, teeth whitening agents, recent dental procedures, bruxism, aggressive brushing, or trauma is usually found on inquiry.

Because they exhibit radial growth, which can be rapid, they can often be mistaken for melanoma. Melanomas most commonly affect the hard palate.

A thorough oral exam to assess for the presence of multiple spots should be performed as well as a full skin exam to assess for concomitant nevi or suspicious melanotic lesions. These lesions tend to regress spontaneously and may be characterized by rapid growth before stabilization and regression. In rare instances, patients may present with diffuse oral pigmentation.[10]

A family history of pigmented oral lesions or polyposis may suggest Peutz-Jegher syndrome.

The palate is more commonly affected by multifocal than by solitary lesions. Multifocal lesions are usually more black with a mean diameter of each lesion smaller than the solitary ones. The number of these lesions typically ranges between two and five.[4]

Evaluation

Since oral melanoacanthomas do not exhibit any distinctive clinical features, the diagnosis is made by histopathological findings. Immunohistochemical staining with monoclonal antibodies for S-100 and HMB-45 is a useful tool to confirm the presence of melanocyte dendritic cells.[11]

Treatment / Management

Oral melanoacanthoma is a benign entity without any known risk of malignant transformation, so once diagnosed, further treatment is not necessary.[12] Clinical regression of the lesion is even seen after incisional biopsy with a high frequency. If treatment is desired, the lesion may be excised surgically with a negative margin. Argon plasma coagulation has also been utilized with promising results.[13] Cryotherapy, curettage, and the topic application of fluorouracil 5% are other treatment options described in the literature.(B3)

Differential Diagnosis

The differential diagnosis of pigmented oral lesions ranges from various benign entities to rare oral melanoma. Oral melanoacanthoma usually presents as a solitary lesion but in rare instances may be multifocal or diffuse in nature.Melanocytic benign lesions can be divided into multifocal and solitary. Multi-focal lesions should include smokers' pigmentation of the mucosa, which occurs in those who smoke or chew tobacco.

Multifocal hyperpigmented melanocytic lesions can be caused by certain conditions, such as HIV, syndromes like Peutz-Jeghers, neurofibromatosis, McCune-Albright syndrome, Addison's disease, Laugier-Hunziker, and some drugs including azathioprines, antimalarials, cytotoxic agents, such as bleomycin, and contraceptives.

Non-melanocytic diffuse pigmentation may be due to heavy metals, trauma, or hemochromatosis.

In focal pigmentation, differential diagnoses include melanotic macule, which is most common, followed by melanocytic nevi, and more rarely oral melanoma.

Addison disease causes hyperpigmentation of the oral mucosa by increased melanocyte-stimulating hormone due to increased production of adrenocorticotropic hormone (ACTH) in the presence of failing adrenal glands.Laugier-Hunziker syndrome is a rare cause of oral and cutaneous hyperpigmentation that typically occurs in older caucasian males with an absence of associated hamartomas or malignancies and is a diagnosis of exclusion.[14][15]

Up to 18% of human immunodeficiency virus patients may be affected by oral hyperpigmentation. It most often affects the gingival mucosa and may develop irrespective of antiretroviral therapy, CD4 counts, or disease duration.[16]

Peutz-Jeghers syndrome (PJS) is an autosomal dominant disease with benign hyperpigmented buccal macules and gastrointestinal hamartomas or polyposis. It is associated with stomach, colon, and pancreatic cancer, among others. It often presents in childhood, and patients will have oral and cutaneous hyperpigmented macules that usually cover the lips, oral mucosa, and perioral area. Patients presenting with oral or perioral hyperpigmentation and gastrointestinal polyps or family history suggestive of PJS should undergo genetic testing.[17][18]

Amalgam tattoo or focal argirosis typically presents as blue or greyish tinge, located in the mucosa near a previous dental filling, dental implant, or prosthesis. These lesions can be detected on x-rays. A biopsy will show tiny black deposits in the connective tissue, typically aligned along the collagen fibers and blood vessels. If the patient's history does not very clearly point towards a benign or non-melanocytic diagnosis, then a biopsy of the lesion should be performed.[19]

Oral melanoma should be suspected in instances of lesions displaying the ABCDE criteria, which include Asymmetry, Border irregularity, change in Color, Diameter >6mm, and Elevation, or the presence of a raised lesion. Oral melanoma accounts for almost a quarter of melanoma of the head and neck. It is associated with a very poor prognosis, approximately 30% five-year survival, because of its propensity for metastasis and local recurrence. Despite its rarity, since oral melanoma carries such a poor prognosis, a biopsy should be performed to rule it out.[20][21]

Prognosis

Oral melanoacanthoma has been reported to spontaneously regress or resolve after the biopsy procedure or cessation of offending agents.[3] Oral melanoacanthoma lesions can be present for periods of weeks up to a year and may exhibit growth or progression before patients seeking medical treatment.[4] In some cases, a solitary lesion may progress to multiple lesions or diffuse pigmentation.[12] There are no reported cases of malignancy with features of atypia or dysplasia.[22]

Complications

There are no reported oral melanoacanthoma complications. However, difficulties are mostly secondary to surgical excisions, such as scarring and post-operative pain.

Not biopsying an oral pigmented lesion may cause a missed diagnosis of a malignancy, so it behooves the oral surgeon to biopsy all pigmented lesions unless there is a clear component of the patient's history to ascertain the etiology.

Deterrence and Patient Education

Patients should be educated on the potential association with offending agents or dental implants with oral melanoacanthoma. In many cases, the lesion resolves with cessation of the offending agent over time.[4]

Gleaning information from patients about the use of off-label dental agents or implants is an essential part of history-taking. 

Despite oral melanoacanthoma being a benign lesion, educating patients about the similarity, it has in appearance to oral melanoma, and the importance of follow up is critical.

Enhancing Healthcare Team Outcomes

Educating dentists, oral surgeons, and primary care physicians on the benign course, reactive nature, diagnosis, management, and oral melanoacanthoma treatment is essential. It will relieve clinicians' and patients' stress when a pigmented lesion arises in the oral cavity, particularly when there is an inciting factor or irritant.

The primary care physician sometimes may first see pigmented lesions; timely referral to a dentist or an oral or head and neck surgeon for a biopsy is essential since the clinical appearance of oral melanoacanthoma is nondiagnostic.Nonetheless, the lesion does not require treatment, and elimination or cessation of local irritants and periodic follow-ups are the recommended interventions.

Educating patients about the importance of letting their dentist or primary care clinician know about any new pigmentation in the mouth is essential and coordinating for follow-up exams until the lesion is resolved.

References


[1]

Cantudo-Sanagustín E,Gutiérrez-Corrales A,Vigo-Martínez M,Serrera-Figallo MÁ,Torres-Lagares D,Gutiérrez-Pérez JL, Pathogenesis and clinicohistopathological caractheristics of melanoacanthoma: A systematic review. Journal of clinical and experimental dentistry. 2016 Jul;     [PubMed PMID: 27398186]

Level 1 (high-level) evidence

[2]

Lakshminarayanan V,Ranganathan K, Oral melanoacanthoma: a case report and review of the literature. Journal of medical case reports. 2009 Jan 13     [PubMed PMID: 19144105]

Level 3 (low-level) evidence

[3]

Goode RK,Crawford BE,Callihan MD,Neville BW, Oral melanoacanthoma. Review of the literature and report of ten cases. Oral surgery, oral medicine, and oral pathology. 1983 Dec;     [PubMed PMID: 6581460]

Level 3 (low-level) evidence

[4]

Yarom N,Hirshberg A,Buchner A, Solitary and multifocal oral melanoacanthoma. International journal of dermatology. 2007 Dec;     [PubMed PMID: 18173514]

Level 3 (low-level) evidence

[5]

Fatahzadeh M,Sirois DA, Multiple intraoral melanoacanthomas: a case report with unusual findings. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2002 Jul;     [PubMed PMID: 12193894]

Level 3 (low-level) evidence

[6]

Gondak RO,da Silva-Jorge R,Jorge J,Lopes MA,Vargas PA, Oral pigmented lesions: Clinicopathologic features and review of the literature. Medicina oral, patologia oral y cirugia bucal. 2012 Nov 1;     [PubMed PMID: 22549672]


[7]

Babu SP,Agila S,Sivaranjani P,Kashyap V, An unusual clinical presentation of gingival melanoacanthoma. Journal of Indian Society of Periodontology. 2013 Sep;     [PubMed PMID: 24174763]

Level 3 (low-level) evidence

[8]

Contreras E,Carlos R, Oral melanoacanthosis (melanoachantoma): report of a case and review of the literature. Medicina oral, patologia oral y cirugia bucal. 2005 Jan-Feb;     [PubMed PMID: 15627902]

Level 3 (low-level) evidence

[9]

Carlos-Bregni R,Contreras E,Netto AC,Mosqueda-Taylor A,Vargas PA,Jorge J,León JE,de Almeida OP, Oral melanoacanthoma and oral melanotic macule: a report of 8 cases, review of the literature, and immunohistochemical analysis. Medicina oral, patologia oral y cirugia bucal. 2007 Sep 1;     [PubMed PMID: 17767102]

Level 3 (low-level) evidence

[10]

Gupta AA,Nainani P,Upadhyay B,Kavle P, Oral melanoacanthoma: A rare case of diffuse oral pigmentation. Journal of oral and maxillofacial pathology : JOMFP. 2012 Sep;     [PubMed PMID: 23248484]

Level 3 (low-level) evidence

[11]

Barrett AW,Raja AM, The immunohistochemical identification of human oral mucosal melanocytes. Archives of oral biology. 1997 Jan;     [PubMed PMID: 9134118]


[12]

Marocchio LS,Júnior DS,de Sousa SC,Fabre RF,Raitz R, Multifocal diffuse oral melanoacanthoma: a case report. Journal of oral science. 2009 Sep;     [PubMed PMID: 19776516]

Level 3 (low-level) evidence

[13]

Andrews BT,Trask DK, Oral melanoacanthoma: a case report, a review of the literature, and a new treatment option. The Annals of otology, rhinology, and laryngology. 2005 Sep;     [PubMed PMID: 16240929]

Level 3 (low-level) evidence

[14]

Paul J,Harvey VM,Sbicca JA,O'Neal B, Laugier-Hunziker syndrome. Cutis. 2017 Sep;     [PubMed PMID: 29121134]


[15]

Rangwala S,Doherty CB,Katta R, Laugier-Hunziker syndrome: A case report and review of the literature. Dermatology online journal. 2010 Dec 15;     [PubMed PMID: 21199635]

Level 3 (low-level) evidence

[16]

Chandran R,Feller L,Lemmer J,Khammissa RA, HIV-Associated Oral Mucosal Melanin Hyperpigmentation: A Clinical Study in a South African Population Sample. AIDS research and treatment. 2016;     [PubMed PMID: 27006825]


[17]

Tomlinson IP,Houlston RS, Peutz-Jeghers syndrome. Journal of medical genetics. 1997 Dec;     [PubMed PMID: 9429144]


[18]

Syngal S,Brand RE,Church JM,Giardiello FM,Hampel HL,Burt RW, ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. The American journal of gastroenterology. 2015 Feb;     [PubMed PMID: 25645574]


[19]

Müller S, Melanin-associated pigmented lesions of the oral mucosa: presentation, differential diagnosis, and treatment. Dermatologic therapy. 2010 May-Jun;     [PubMed PMID: 20597941]


[20]

Sreeja C,Ramakrishnan K,Vijayalakshmi D,Devi M,Aesha I,Vijayabanu B, Oral pigmentation: A review. Journal of pharmacy     [PubMed PMID: 26538887]


[21]

Feller L,Khammissa RAG,Lemmer J, A Review of the Aetiopathogenesis and Clinical and Histopathological Features of Oral Mucosal Melanoma. TheScientificWorldJournal. 2017;     [PubMed PMID: 28638859]


[22]

Galindo-Moreno P,Padial-Molina M,Gómez-Morales M,Aneiros-Fernández J,Mesa F,O'Valle F, Multifocal oral melanoacanthoma and melanotic macula in a patient after dental implant surgery. Journal of the American Dental Association (1939). 2011 Jul     [PubMed PMID: 21719804]

Level 3 (low-level) evidence